| 摘要 |
<p>Described are new 17β-aryl ester carboxylates of 4-aza-5α-androstan-3-ones and related compounds and the use of such compounds as 5α-reductase inhibitors for treatment of benign prostatic hyperplasia and other hyperandrogenetic related disorders.</p> |
